These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 34147618

  • 1. Exploring the mechanisms of anti-ovarian cancer of Hedyotis diffusa Willd and Scutellaria barbata D. Don through focal adhesion pathway.
    Xu X, Chen F, Zhang L, Liu L, Zhang C, Zhang Z, Li W.
    J Ethnopharmacol; 2021 Oct 28; 279():114343. PubMed ID: 34147618
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of Therapeutic Mechanism of Hedyotis Diffusa Willd (HDW)‒ Scutellaria Barbata (SB) in Clear Cell Renal Cell Carcinoma via Singlecell RNA Sequencing and Network Pharmacology.
    Bai Y, Chen R, Sun J, Guo Y.
    Comb Chem High Throughput Screen; 2024 Oct 28; 27(6):910-921. PubMed ID: 37526191
    [Abstract] [Full Text] [Related]

  • 3. Network-based pharmacology-based research on the effect and mechanism of the Hedyotis diffusa-Scutellaria Barbata pair in the treatment of hepatocellular carcinoma.
    Hou C, Wen X, Yan S, Gu X, Jiang Y, Chen F, Liu Y, Zhu Y, Liu X.
    Sci Rep; 2024 Jan 10; 14(1):963. PubMed ID: 38200019
    [Abstract] [Full Text] [Related]

  • 4. [Mechanism of "Scutellaria barbata-Hedyotis diffusa" against breast cancer based on network pharmacology].
    Jing XU, Feng-Qin S, Ke-Xin DU, Jia D, Dong-Yun LI.
    Zhongguo Zhong Yao Za Zhi; 2020 Sep 10; 45(18):4448-4454. PubMed ID: 33164375
    [Abstract] [Full Text] [Related]

  • 5. Network pharmacology and experimental verification study on the mechanism of Hedyotis diffusa Willd in treating colorectal cancer.
    Yuan X, Huang H, Yu C, Tang Z, Li Y.
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Sep 10; 397(9):6507-6521. PubMed ID: 38446216
    [Abstract] [Full Text] [Related]

  • 6. Ethyl Acetate Fraction from Hedyotis Diffusa Plus Scutellaria Barbata Inhibits the Progression of Breast Cancer via Targeting LMO1 and AKT/Mtor Signaling Pathway.
    Li Z, Li J, Liu X, Sun Z, Sun X.
    Comb Chem High Throughput Screen; 2024 Sep 10; 27(12):1735-1744. PubMed ID: 37711008
    [Abstract] [Full Text] [Related]

  • 7. Scutellaria barbata and Hedyotis diffusa herb pair for breast cancer treatment: Potential mechanism based on network pharmacology.
    Ma TT, Zhang GL, Dai CF, Zhang BR, Cao KX, Wang CG, Yang GW, Wang XM.
    J Ethnopharmacol; 2020 Sep 15; 259():112929. PubMed ID: 32416245
    [Abstract] [Full Text] [Related]

  • 8. The anti-tumor effect and bioactive phytochemicals of Hedyotis diffusa willd on ovarian cancer cells.
    Zhang L, Zhang J, Qi B, Jiang G, Liu J, Zhang P, Ma Y, Li W.
    J Ethnopharmacol; 2016 Nov 04; 192():132-139. PubMed ID: 27426510
    [Abstract] [Full Text] [Related]

  • 9. Scutellaria barbata D.Don and Oldenlandia diffusa (Willd.) Roxb crude extracts inhibit hepatitis-B-virus-associated hepatocellular carcinoma growth through regulating circRNA expression.
    Yang PW, Chen TT, Zhao WX, Liu GW, Feng XJ, Wang SM, Pan YC, Wang Q, Zhang SH.
    J Ethnopharmacol; 2021 Jul 15; 275():114110. PubMed ID: 33864890
    [Abstract] [Full Text] [Related]

  • 10. Anti-tumor effect of Scutellaria barbata D. Don extracts on ovarian cancer and its phytochemicals characterisation.
    Zhang L, Ren B, Zhang J, Liu L, Liu J, Jiang G, Li M, Ding Y, Li W.
    J Ethnopharmacol; 2017 Jul 12; 206():184-192. PubMed ID: 28571726
    [Abstract] [Full Text] [Related]

  • 11. Investigating the Multi-Target Pharmacological Mechanism of Hedyotis diffusa Willd Acting on Prostate Cancer: A Network Pharmacology Approach.
    Song Y, Wang H, Pan Y, Liu T.
    Biomolecules; 2019 Oct 09; 9(10):. PubMed ID: 31600936
    [Abstract] [Full Text] [Related]

  • 12. Hedyotis diffusa-Sculellaria barbata (HD-SB) suppresses the progression of colorectal cancer cells via the hsa_circ_0039933/hsa-miR-204-5p/wnt11 axis.
    Zhu D, Yuan S, Chen C.
    Sci Rep; 2023 Aug 16; 13(1):13331. PubMed ID: 37587207
    [Abstract] [Full Text] [Related]

  • 13. Transcriptional regulation of G2/M regulatory proteins and perturbation of G2/M Cell cycle transition by a traditional Chinese medicine recipe.
    Hnit SST, Yao M, Xie C, Ge G, Bi L, Jin S, Jiao L, Xu L, Long L, Nie H, Jin Y, Rogers L, Suchowerska N, Wong M, Liu T, De Souza P, Li Z, Dong Q.
    J Ethnopharmacol; 2020 Apr 06; 251():112526. PubMed ID: 31893534
    [Abstract] [Full Text] [Related]

  • 14. Enhanced anticancer effects of Scutellaria barbata D. Don in combination with traditional Chinese medicine components on non-small cell lung cancer cells.
    Wang Q, Acharya N, Liu Z, Zhou X, Cromie M, Zhu J, Gao W.
    J Ethnopharmacol; 2018 May 10; 217():140-151. PubMed ID: 29458146
    [Abstract] [Full Text] [Related]

  • 15. Exploration of the effect and mechanism of Scutellaria barbata D. Don in the treatment of ovarian cancer based on network pharmacology and in vitro experimental verification.
    Zhang J, Qi C, Li H, Ding C, Wang L, Wu H, Dai W, Wang C.
    Medicine (Baltimore); 2023 Dec 22; 102(51):e36656. PubMed ID: 38134066
    [Abstract] [Full Text] [Related]

  • 16. Scutellaria barbata D.Don and Scleromitrion diffusum (Willd.) R.J.Wang inhibits the progression of triple negative breast cancer though the activation inhibition of NF-κB triggered by CAFs-derived IL6.
    Pan Y, Ma T, Chen D, Wang Y, Peng Y, Lu T, Yin X, Li H, Zhang G, Wang X.
    J Ethnopharmacol; 2024 Dec 05; 335():118656. PubMed ID: 39121924
    [Abstract] [Full Text] [Related]

  • 17. Antitumor Effects and the Compatibility Mechanisms of Herb Pair Scleromitrion diffusum (Willd.) R. J. Wang-Sculellaria barbata D. Don.
    Lu L, Zhan S, Liu X, Zhao X, Lin X, Xu H.
    Front Pharmacol; 2020 Dec 05; 11():292. PubMed ID: 32265701
    [Abstract] [Full Text] [Related]

  • 18. Molecular Targets and Mechanisms of Hedyotis diffusa-Scutellaria barbata Herb Pair for the Treatment of Colorectal Cancer Based on Network Pharmacology and Molecular Docking.
    Yang Z, Lu S, Tang H, Qu J, Wang B, Wang Y, Pan G, Rao B.
    Evid Based Complement Alternat Med; 2022 Dec 05; 2022():6186662. PubMed ID: 35707465
    [Abstract] [Full Text] [Related]

  • 19. Regulation of IGF-I production and proliferation of human leiomyomal smooth muscle cells by Scutellaria barbata D. Don in vitro: isolation of flavonoids of apigenin and luteolin as acting compounds.
    Kim DI, Lee TK, Lim IS, Kim H, Lee YC, Kim CH.
    Toxicol Appl Pharmacol; 2005 Jun 15; 205(3):213-24. PubMed ID: 15922007
    [Abstract] [Full Text] [Related]

  • 20. A drug-biomarker interaction model to predict the key targets of Scutellaria barbata D. Don in adverse-risk acute myeloid leukaemia.
    Wang T, Lyu CY, Jiang YH, Dong XY, Wang Y, Li ZH, Wang JX, Xu RR.
    Mol Divers; 2021 Nov 15; 25(4):2351-2365. PubMed ID: 32676746
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.